title: Are BIC (miR-155) polymorphisms associated with eczema susceptibility?
authors.forename: Annika
authors.initials: A
authors.lastname: Sääf
authors.forename: Ingrid
authors.initials: I
authors.lastname: Kockum
authors.forename: Carl-Fredrik
authors.initials: CF
authors.lastname: Wahlgren
authors.forename: Ning
authors.initials: N
authors.lastname: Xu
authors.forename: Enikö
authors.initials: E
authors.lastname: Sonkoly
authors.forename: Mona
authors.initials: M
authors.lastname: Ståhle
authors.forename: Magnus
authors.initials: M
authors.lastname: Nordenskjöld
authors.forename: Maria
authors.initials: M
authors.lastname: Bradley
authors.forename: Andor
authors.initials: A
authors.lastname: Pivarcsi
mesh_terms: D000293:Adolescent; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D002648:Child; D004485:Eczema / Q000097:blood / Q000235:genetics* / Q000276:immunology; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D035683:MicroRNAs / Q000235:genetics*; D016017:Odds Ratio; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D015854:Up-Regulation; D055815:Young Adult
chemical_list: D015415:Biomarkers; C524942:MIRN155 microRNA, human; D035683:MicroRNAs; D007073:Immunoglobulin E